Literature DB >> 4693647

Determination of iodothyronine absorption and conversion of L-thyroxine (T 4 ) to L-triiodothyronine (T 3 ) using turnover rate techniques.

M I Surks, A R Schadlow, J M Stock, J H Oppenheimer.   

Abstract

The absorption of L-thyroxine (T(4)) and L-triiodothyronine (T(3)) and the fractional rate of conversion of T(4) to T(3) were determined from the turnover rates of T(4) and T(3) in seven patients without endogenous thyroid function during separate treatment periods with these iodothyronines. Serum T(3) concentration was measured by a radioimmunoassay procedure in which the iodothyronines are separated from the plasma proteins before incubation with anti-T(3) antibody. Metabolic clearance rates were calculated by an integral (noncompartmental) approach since the use of single compartment kinetics led to a 40% overestimation of the metabolic clearance rate of T(3). Based on the amount of hormone ingested and the observed hormonal turnover rates, the absorption of T(4) and T(3) (iodothyronine turnover/iodothyronine ingested) in man could be estimated. Absorption of T(3) was complete in three subjects but decreased to 43% in a fourth who was suffering from mild congestive heart failure. Mean T(4) absorption was 48.0+/-2.6% (SEM) for seven subjects. The mean fractional rate of T(4) to T(3) conversion determined during T(4) replacement therapy (T(3) turnover/T(4) turnover) was 42.6% (range 30.7-50.8%). Thus, approximately one-half of the T(4) which was deiodinated was converted to T(3) suggesting that monodeiodination is an obligatory step in the peripheral metabolism of T(4). Calculations based on these results together with other available data suggest that under normal physiologic circumstances the major portion of the T(3) pool is derived from monodeiodination of T(4).

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4693647      PMCID: PMC302327          DOI: 10.1172/JCI107244

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  WHOLE-BODY COUNTING OF I-131-LABELED THYROXINE.

Authors:  T H ODDIE; D A FISHER; C ROGERS
Journal:  J Clin Endocrinol Metab       Date:  1964-07       Impact factor: 5.958

2.  DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING.

Authors:  B E MURPHY; C J PATTEE
Journal:  J Clin Endocrinol Metab       Date:  1964-02       Impact factor: 5.958

Review 3.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

4.  THE EXTRATHYROIDAL DISTRIBUTION OF 131-I THYROXINE.

Authors:  B BLOMSTEDT; L O PLANTIN
Journal:  Acta Endocrinol (Copenh)       Date:  1965-04

5.  Determination of iodine compounds in serum. I. Serum thyroxine in the presence of some iodine contaminants.

Authors:  V J PILEGGI; N D LEE; O J GOLUB; R J HENRY
Journal:  J Clin Endocrinol Metab       Date:  1961-10       Impact factor: 5.958

6.  Radioimmunoassay for triiodothyronine (T 3 ): I. Affinity and specificity of the antibody for T 3 .

Authors:  H Gharib; R J Ryan; W E Mayberry; T Hockert
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

7.  Triiodothyronine radioimmunoassay.

Authors:  J Lieblich; R D Utiger
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

8.  A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement.

Authors:  M I Surks; A R Schadlow; J H Oppenheimer
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

9.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

10.  Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

View more
  39 in total

1.  The significance of triiodothyronine.

Authors:  I Chopra
Journal:  Calif Med       Date:  1973-10

2.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

4.  An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.

Authors:  I J Chopra
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

5.  Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.

Authors:  M Saberi; F H Sterling; R D Utiger
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

6.  Thyroid function and thyroid hormone metabolism in elderly people. Low T3-syndrome in old age?

Authors:  J Herrmann; E Heinen; H J Kröll; K H Rudorff; H L Krüskemper
Journal:  Klin Wochenschr       Date:  1981-04-01

7.  Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats.

Authors:  J E Silva; M B Gordon; F R Crantz; J L Leonard; P R Larsen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  L-triiodothyronine and L-reverse-triiodothyronine generation in the human polymorphonuclear leukocyte.

Authors:  K A Woeber
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

9.  Concentration of L-thyroxine and L-triiodothyronine specifically bound to nuclear receptors in rat liver and kidney. Quantitative evidence favoring a major role of T3 in thyroid hormone action.

Authors:  M I Surks; J H Oppenheimer
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

10.  Thyroid hormonelike actions of 3,3',5'-L-triiodothyronine nad 3,3'-diiodothyronine.

Authors:  S S Papavasiliou; J A Martial; K R Latham; J D Baxter
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.